Explore the positions available across Oxford Science Enterprises

Locations

England, UK · Oxford, UK · Oxfordshire, UK · West Street / River Street, Boston, MA, USA

industry

Biotechnology

Size

51-200 employees

Stage

IPO

founded in

2018

Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders.

Something looks off?
Open jobs at Pepgen

On-site & Remote